Edition:
India

aTyr Pharma Inc (LIFE.OQ)

LIFE.OQ on NASDAQ Stock Exchange Capital Market

4.00USD
10 Aug 2020
Change (% chg)

-- (--)
Prev Close
$4.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
25,662
52-wk High
$7.62
52-wk Low
$2.15

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2020 Mar '20 8.06 0.255
FY 2019 Dec '19 0.14 -1.533
Sep '19 0.18 -1.468
Jun '19 0.09 -1.802
Mar '19 0.00 -2.540
FY 2018 Dec '18 0.00 -2.918
Sep '18 0.00 -3.336
Jun '18 0.00 -4.884
Mar '18 0.00 -5.012
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-20 3 0.36 1.00 0.00 --
Quarter Ending Dec-20 3 0.37 1.00 0.00 --
Year Ending Dec-20 3 9.18 11.07 8.18 --
Year Ending Dec-21 3 0.10 0.30 0.00 --
Earnings (per share)
Quarter Ending Sep-20 3 -0.80 -0.64 -1.04 --
Quarter Ending Dec-20 3 -0.82 -0.68 -1.01 --
Year Ending Dec-20 3 -2.33 -1.94 -2.88 -16.98
Year Ending Dec-21 3 -3.08 -2.07 -4.57 -13.02
LT Growth Rate (%) 1 13.00 13.00 13.00 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -20.51 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for aTyr Pharma Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 70.63 64.75 97 --
13 Week 53.57 46.09 91 --
26 Week 65.38 52.81 87 --
52 Week 80.98 53.39 85 --
YTD 150.00 119.55 92 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 64.32%
# of Holders: 33
Total Shares Held: 6,015,956
3 Mo. Net Change: -10,434
# New Positions: 0
# Closed Positions: 2
# Increased Positions: 1
# Reduced Positions: 2
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.